Zachęca się pracowników opieki zdrowotnej, aby w pełni uwzględniali te wytyczne
ESC/EACTS, gdy dokonują oceny klinicznej, a także kiedy określają i realizują medyczne …

Background Percutaneous coronary intervention (PCI) relieves angina in patients with
stable ischemic heart disease, but clinical trials have not shown that it improves survival …

Background: Treatment of multivessel coronary artery disease with traditional single-arterial
coronary artery bypass graft (SA-CABG) has been associated with superior intermediate …

Background Transcatheter aortic valve implantation (TAVI) has been established as a
reasonable alternative to surgical aortic valve replacement (SAVR) in patients with severe …

Background—Decisions to proceed with surgical versus percutaneous revascularization for
multivessel coronary artery disease are often based on subtle clinical information that may …

Background: Few recent studies have compared the outcomes of coronary artery bypass
graft (CABG) surgery with percutaneous coronary interventions (PCIs) in patients with …

Cardiovascular disease is the leading cause of morbidity and mortality in people with
diabetes mellitus. Patients with diabetes mellitus have a 2-to 4-fold increase in risk of …

Several randomized controlled trials and observational studies have compared outcomes of
percutaneous coronary interventions (PCIs) with drug-eluting stents (DESs) and coronary …

Objective In patients with multivessel disease and proximal left anterior descending artery
(LAD) involvement, the best revascularisation strategy is still unclear. We assess outcomes …

Competitive flow reduces the patency of arterial grafts after coronary bypass surgery.
Competitive flow is dynamic, relative, and to a certain extent unavoidable. The preoperative …